#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary angioedema with C1 esterase inhibitor deficiency Polyneuropathy Thrombocytosis Depression Pulmonary fibrosis Hormone-dependent prostate cancer Hepatoblastoma Squamous cell carcinoma of the vulva Bronchopulmonary aspergillosis Antisynthetase syndrome Advanced systemic mastocytosis Sexually transmitted disease Focal segmental glomerulosclerosis CDKL5 deficiency disorder KBG syndrome More trials…

    Learn about Rare Diseases

    Primary hyperoxaluria Phenylketonuria – Basic Information Gaucher’s disease type III – Trials in Disease Encephalitis autoimmune – Life with Disease Primary immunodeficiency syndrome – Diagnostics Andersen-Tawil syndrome – Diagnostics Haemophilia A with anti factor VIII – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Mastocytosis Haemophilia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Esketamine Hydrochloride Valproic Acid Haloperidol Decanoate Mirvetuximab Soravtansine Pegaspargase Paxalisib Iph6501 Remdesivir Siponimod Fumaric Acid Triptorelin Acetate Cefotaxime Patisiran Giroctocogene Fitelparvovec Vismodegib Anhydrous Cyclophosphamide Imsidolimab PICLIDENOSON Inclisiran Lsta1 Tamuzimod Acetate More therapies…

    Learn about Your Condition

    Fracture infection Chronic lymphocytic leukaemia Osteopenia Tissue anoxia White matter lesion Pharyngeal cancer stage II Proteinuria Ehlers-Danlos syndrome Ovarian cancer recurrent External cephalic version Nasopharyngeal cancer Bone hypertrophy Procedural anxiety Orthostatic hypotension Meningioma malignant More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of xaluritamig compared to cabazitaxel or androgen receptor therapy for patients with metastatic castration-resistant prostate cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Xaluritamig
    • Abiraterone Acetate
    • Cabazitaxel
    Austria Belgium Denmark France Germany Greece +5

  • A study testing trimodulin in hospitalized adult patients with community-acquired pneumonia including COVID-19 pneumonia

    Not recruiting

    3 1
    Investigated Diseases:
    • Pneumonia
    • COVID-19
    Investigated Drugs:
    • Trimodulin (Human Igm, Iga, Igg Solution)
    Austria Belgium France Germany Hungary Latvia +3

  • A study comparing BNT113 combined with pembrolizumab versus pembrolizumab alone for patients with HPV16-positive head and neck cancer that cannot be removed by surgery

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Pembrolizumab
    • Rbl015.2
    • Rbl016.2
    Austria Belgium Czechia France Germany Hungary +5

  • A Study Comparing Telisotuzumab Adizutecan to Trifluridine, Tipiracil, and Bevacizumab in Adults with Refractory Metastatic Colorectal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Tipiracil Hydrochloride
    • Trifluridine
    • Bevacizumab
    France Germany Italy The Netherlands Poland Spain

  • Study of nedosiran for patients with primary hyperoxaluria type 1 and severe kidney impairment with or without dialysis

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Nedosiran
    Germany Italy Spain

  • A study testing maridebart cafraglutide for weight loss in adults with overweight or obesity, with or without type 2 diabetes

    Not recruiting

    2 1
    Investigated Diseases:
    • Overweight
    • Obesity
    Investigated Drugs:
    • Maridebart Cafraglutide
    Czechia Germany Hungary Poland Spain
Previous Page
1 … 931 932 933 934 935 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!